---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-004713"
form_type: "8-K"
ticker: "HSTM"
cik: "0001095565"
company_name: "HEALTHSTREAM INC"
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T22:39:45.392837+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HealthStream Q4 net income +87% to $4.6M; raises quarterly dividend 12%

## Summary
- Q4 revenue $70.6M (+3% YoY); net income $4.6M (+87%); diluted EPS $0.15 vs $0.08 in Q4 2022.
- FY2023 revenue $279.1M (+5%); net income $15.2M (+26%); adjusted EBITDA $61.3M (+15%).
- Quarterly dividend increased 12% to $0.028/share; payable March 22, 2024 to holders of record March 11.
- 2024 guidance: revenue $292-296M, adjusted EBITDA $64.5-67.5M, capital expenditures $28-30M.
- Repurchased $8.9M in shares during 2023 under $10M authorization; program expires March 31, 2024.

## SEC filing metadata
- accession: 0001437749-24-004713
- form_type: 8-K
- ticker: HSTM
- cik: 0001095565
- company_name: HEALTHSTREAM INC
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095565/000143774924004713/0001437749-24-004713-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095565/000143774924004713/hstm20231116_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-004713
- JSON: https://secwatch.observer/filing/0001437749-24-004713.json
- Plain text: https://secwatch.observer/filing/0001437749-24-004713.txt

## Key facts
- Earnings Releases
  HEALTHSTREAM INC reported the full year 2024 results: revenue $292.0 - $296.0 million. Guidance initiated.
  - Period: the full year 2024
  - Revenue: $292.0 - $296.0 million
  - Guidance: initiated
  - Result: guidance update
  source text: Full Year 2024 Guidance Low High Revenue $ 292.0 - $ 296.0 million Adjusted EBITDA 1 $ 64.5 - $ 67.5 million Capital Expenditures $ 28.0 - $ 30.0 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1095565/000143774924004713/0001437749-24-004713-index.htm
- Earnings Releases
  HEALTHSTREAM INC reported the fourth quarter ended December 31, 2023 results: revenue $70.6 million, net income $4.6 million, EPS $0.15 per share (diluted). Guidance initiated.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: $70.6 million
  - Net income: $4.6 million
  - EPS: $0.15 per share (diluted)
  - Guidance: initiated
  - Result: reported results
  source text: Fourth Quarter 2023 ● Revenues of $70.6 million, up 3% from $68.5 million in the fourth quarter of 2022 ● Operating income of $4.3 million, up 38% from $3.1 million in the fourth quarter of 2022 ● Net income of $4.6 million, up 87% from $2.5 million in the fourth quarter of 2022 ● Earnings per share (EPS) of $0.15 per share (diluted), up from $0.08 per share (diluted) in the fourth quarter of 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1095565/000143774924004713/0001437749-24-004713-index.htm
- Earnings Releases
  HEALTHSTREAM INC reported the full year ended December 31, 2023 results: revenue $279.1 million, net income $15.2 million, EPS $0.50 per share (diluted). Guidance initiated.
  - Period: the full year ended December 31, 2023
  - Revenue: $279.1 million
  - Net income: $15.2 million
  - EPS: $0.50 per share (diluted)
  - Guidance: initiated
  - Result: reported results
  source text: Full-Year 2023 ● Revenues of $279.1 million, up 5% from $266.8 million in 2022 ● Operating income of $16.0 million, up 29% from $12.4 million in 2022 ● Net income of $15.2 million, up 26% from $12.1 million in 2022 ● Earnings per share (EPS) of $0.50 per share (diluted) in 2023 , compared to $0.39 per share (diluted) in 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1095565/000143774924004713/0001437749-24-004713-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.